OliX Pharmaceuticals | RoundOS

Weekly digest by email

Loading companies…

OliX Pharmaceuticals | RoundOS

Weekly digest by email

Funding history

1 round · 1 with disclosed amounts

Announced	Round	Amount	Investors
Jun 4, 2026	Strategic	₩110B	BOLD — Role not disclosedWeiss Asset Management LP — Role not disclosed

Investors

BOLDStrategic Weiss Asset Management LPStrategic

Coverage

Jun 4, 2026OliX Pharmaceuticals · Strategic

Similar companies

AusperBioDevelops oligonucleotide therapeutics targeting chronic hepatitis B$120M · Series C

MetriportOpen-source healthcare data infrastructure unifying patient records for clinicians$26M · Series A

ProFound TherapeuticsUses AI and proteomics to discover drug targets and biomarkers for preeclampsia and eclampsia$35M · Strategic

Sources

olixpharma.com ↗